Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Ovarian Epithelial × Epirubicin × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 78 Triple Negative Breast Neoplasms 15 Stomach Neoplasms 12 Inflammatory Breast Neoplasms 11 Esophageal Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 5 Testicular Neoplasms 3 Lymphoma 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms, Germ Cell and Embryonal 2 Lymphoma, B-Cell, Marginal Zone 2 Carcinoma, Hepatocellular 2 Adenocarcinoma Of Esophagus 2 Women With Primary Breast Cancer 1 Upper Tract Urothelial Carcinoma 1 Thymoma 1 Testicular Germ Cell Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Rare Tumour 1 Prostatic Neoplasms 1 Primary Breast Cancer 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Micrometastasis 1 Neoplasm Metastasis 1

Interventions

Carboplatin 41 Paclitaxel 39 Cisplatin 20 Topotecan 15 Gemcitabine 14 Docetaxel 11 Bevacizumab 11 olaparib 6 pembrolizumab 5 liposomal doxorubicin 5 Surgical Procedures, Operative 5 Etoposide 5 Drug Therapy 5 Cyclophosphamide 5 Amifostine 5 catumaxomab 4 Hyperthermic Intraperitoneal Chemotherapy 4 sargramostim 3 rucaparib 3 oregovomab 3 ixabepilone 3 Standard of Care 3 Methylprednisolone 3 Immunohistochemistry 3 Imatinib Mesylate 3 Filgrastim 3 Erlotinib Hydrochloride 3 Cytoreduction Surgical Procedures 3 Capecitabine 3 Albumin-Bound Paclitaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03025477 2021-02-11

CHIMOVIP

Groupe Hospitalier Diaconesses Croix Saint-Simon

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡